Banguis, Wilfred M.
HRN: 19-48-33 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2022
CEFUROXIME 1.5GM (VIAL)
10/25/2022
10/31/2022
IV
1.5gm
Q8
For Removal Of Implant
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes